LAPATINIB AND CAPECITABINE IN THE TREATMENT OF HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES

被引：1
|
作者：
Dubianski, R. [1 ,2 ]
Brewczynska, E. [3 ,4 ]
Lemanska, I. [3 ,4 ]
Szombara, E. [5 ]
Nowecki, Z. I. [6 ]
机构：
[1] MSC Mem Canc Ctr, Breast Canc Clin, Warsaw, Poland
[2] Inst Maria Sklodowska Curie, Warsaw, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr, Dept Breast Canc & Reconstruct Surg, Warsaw, Poland
[4] Inst Oncol, Warsaw, Poland
[5] Marie Curie Oncol Ctr, Warsaw, Poland
[6] Maria Sklodowska Curie Mem Canc Ctr, Deptartment Gastrointestinal Canc, Warsaw, Poland
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu329.47
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
    Kaufman, Bella
    Stein, Steven
    Casey, Michelle A.
    Newstat, Beth O.
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 61 - 65
  • [22] Intracranial Efficacy of Pyrotinib and Capecitabine Combination Therapy in HER2-Positive Breast Cancer with Brain Metastases
    Wang, Congcong
    Xiang, Jinyu
    Zhang, Qingyu
    Li, Jing
    Liu, Yanqing
    Liu, Jiannan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 909 - 917
  • [23] Nanoformulation of lapatinib for HER2-positive breast cancer patients with brain metastasis
    Lee, Joyce S.
    Luo, Juntao
    Desai, Sonal
    Lam, Kit S.
    Li, Tianhong
    CANCER RESEARCH, 2011, 71
  • [24] Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
    Lin, Nancy U.
    Dieras, Veronique
    Paul, Devchand
    Lossignol, Dominique
    Christodoulou, Christos
    Stemmler, Hans-Joachim
    Roche, Henri
    Liu, Minetta C.
    Greil, Richard
    Ciruelos, Eva
    Loibl, Sibylle
    Gori, Stefania
    Wardley, Andrew
    Yardley, Denise
    Brufsky, Adam
    Blum, Joanne L.
    Rubin, Stephen D.
    Dharan, Bernie
    Steplewski, Klaudia
    Zembryki, Denise
    Oliva, Cristina
    Roychowdhury, Debasish
    Paoletti, Paolo
    Winer, Eric P.
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1452 - 1459
  • [25] Lapatinib concentration in cerebrospinal fluid in two patients with HER2-positive metastatic breast cancer and brain metastases
    Gori, S.
    Lunardi, G.
    Inno, A.
    Foglietta, J.
    Cardinali, B.
    Del Mastro, L.
    Crino, L.
    ANNALS OF ONCOLOGY, 2014, 25 (04) : 912 - 913
  • [26] The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis
    Petrelli, Fausto
    Ghidini, Michele
    Lonati, Veronica
    Tomasello, Gianluca
    Borgonovo, Karen
    Ghilardi, Mara
    Cabiddu, Mary
    Barni, Sandro
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 141 - 148
  • [27] Current treatment options for HER2-positive breast cancer patients with brain metastases
    Galanti, Daniele
    Inno, Alessandro
    La Vecchia, Maria
    Borsellino, Nicolo
    Incorvaia, Lorena
    Russo, Antonio
    Gori, Stefania
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 161
  • [28] Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies
    Garcia-Alvarez, Alejandro
    Papakonstantinou, Andri
    Oliveira, Mafalda
    CANCERS, 2021, 13 (12)
  • [29] Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
    Hurvitz, Sara A.
    Kakkar, Reva
    BREAST CANCER-TARGETS AND THERAPY, 2012, 4 : 35 - 51
  • [30] Brain metastases in HER2-positive breast cancer: challenges and opportunities
    Torrejon, Davis
    Di Cosimo, Serena
    ANNALS OF PALLIATIVE MEDICINE, 2012, 1 (03) : 195 - 197
12345